Publication: [An update of the recommendations of the Spanish Neonatology Society for the use of palivizumab as prophylaxis for severe infections due to syncytial respiratory virus in high risk infants].
No Thumbnail Available
Identifiers
Date
2019-10-01
Authors
Sánchez Luna, Manuel
Pérez Muñuzuri, Alejandro
Leante Castellanos, José Luis
Ruiz Campillo, César W
Sanz López, Ester
Benavente Fernández, Isabel
Sánchez Redondo, María Dolores
Rite Gracia, Segundo
en representación de la Comisión de Estándares de la Sociedad Española de Neonatología
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
Description
MeSH Terms
Antiviral Agents
Drug Administration Schedule
Humans
Infant, Newborn
Infant, Premature
Infant, Premature, Diseases
Neonatology
Palivizumab
Practice Guidelines as Topic
Respiratory Syncytial Virus Infections
Risk
Societies, Medical
Spain
Drug Administration Schedule
Humans
Infant, Newborn
Infant, Premature
Infant, Premature, Diseases
Neonatology
Palivizumab
Practice Guidelines as Topic
Respiratory Syncytial Virus Infections
Risk
Societies, Medical
Spain